Article contents
Cocaine use and Opioid Withdrawal Syndrome
Published online by Cambridge University Press: 16 April 2020
Summary
The present study was carried out in 2 successive phases. In the first, 91 inpatients admitted for opioid dependence were evaluated. All were treated with α2-agonists during the withdrawal period. Shortly after admission, a urine sample was taken and analyzed (EMIT and GC/MS). The presence of the cocaine metabolite benzoilecgonine in urine was a predictor of dropout probability during hospitalization (P < 0.01). A second study on a sample of 612 inpatients later admitted for similar reasons was carried out according to a simpler protocol (using only EMIT) in order to replicate the previous results. Again, the presence of benzoilecgonine in urine indicated dropout probability (P = 0.00004). Thus, the use of cocaine prior to admission for a treatment of opiate withdrawal syndrome with α2-agonists seems to predict therapeutic failure.
Keywords
- Type
- Original article
- Information
- Copyright
- Copyright © Elsevier, Paris 1991
References
- 5
- Cited by
Comments
No Comments have been published for this article.